Search results for "Highlights"


 
Results 11 - 20 of about 221 for "Highlights".
Sort by: Relevance | Newest | Oldest

Spotlight on treatment response in Crohn's disease

Recent studies evaluated early versus late response to biologic therapy, treatment response and infection risk, and endoscopic outcomes.
https://gastroenterology.acponline.org/archives/2024/01/26/5.htm
26 Jan 2024

No-biopsy approach can diagnose celiac disease in select adults

IgA anti-tissue transglutaminase levels of at least 10 times the upper limit of normal have a sensitivity of 51% and specificity of 100% for predicting celiac disease in adults referred to secondary care, a meta-analysis found.
https://gastroenterology.acponline.org/archives/2024/01/26/1.htm
26 Jan 2024

Phase 3 study offers evidence on drug dosing for eosinophilic esophagitis

Findings from an industry-funded study showed that using dupilumab weekly, rather than every two weeks, improved symptoms in adults and adolescents with eosinophilic esophagitis.
https://gastroenterology.acponline.org/archives/2023/09/22/2.htm
22 Sep 2023

Medications for AUD appear beneficial in patients with cirrhosis

A systematic review and meta-analysis found that medications for alcohol use disorder (AUD) were associated with 32% more abstinence versus placebo or standard treatment in patients with alcohol-induced cirrhosis.
https://gastroenterology.acponline.org/archives/2023/09/22/1.htm
22 Sep 2023

IBD patients may be at higher risk for CKD

A Swedish study found that 11.8% of patients with inflammatory bowel disease (IBD) were diagnosed with chronic kidney disease (CKD) within 10 years, and their risks of acute kidney injury and kidney stones were also elevated.
https://gastroenterology.acponline.org/archives/2023/08/25/2.htm
25 Aug 2023

Low-dose amitriptyline appears effective as second-line treatment for IBS

Patients with irritable bowel syndrome (IBS) who were randomized to titrated doses of a tricyclic antidepressant had significant improvements in their IBS symptom scores at six months compared to those receiving a placebo, a trial in primary care found.
https://gastroenterology.acponline.org/archives/2023/10/27/2.htm
27 Oct 2023

Concurrent cholinesterase inhibitors, NSAIDs linked to peptic ulcer risk

Risk of peptic ulcers increased ninefold when patients ages 65 years and older took cholinesterase inhibitors and NSAIDs concurrently, a Swedish study found, leading the authors to suggest that the combination be considered potentially inappropriate for older patients.
https://gastroenterology.acponline.org/archives/2023/11/17/2.htm
17 Nov 2023

Prophylactic antibiotics help prevent post-ERCP infections

A randomized trial in Korea found that patients with biliary obstruction who underwent endoscopic retrograde cholangiopancreatography (ERCP) were less likely to develop infection if they received antibiotics before the procedure.
https://gastroenterology.acponline.org/archives/2023/09/22/3.htm
22 Sep 2023

GLP-1 receptor agonists may affect colonoscopy bowel prep

A retrospective cohort study found that patients taking glucagon-like peptide-1 (GLP-1) receptor agonists for diabetes or obesity had lower-quality bowel prep for colonoscopy and were more likely to be called back for a repeat test.
https://gastroenterology.acponline.org/archives/2023/10/27/3.htm
27 Oct 2023

Alcohol abstinence not required for direct-acting antivirals to cure HCV, study finds

Restricting access to direct-acting antiviral therapy because of alcohol use creates an unnecessary barrier for patients with hepatitis C virus (HCV) infection, according to the authors of a recent study.
https://gastroenterology.acponline.org/archives/2023/10/27/1.htm
27 Oct 2023

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next